These findings suggest that RP11-317-J19.1, PTP4A1, and BNIP3 may play crucial roles in restraining cancer aggressiveness; thus, they serve as strong predictors of breast cancer bone metastasis. Here, PTP4A1 is linked to breast carcinoma.